Rani Therapeutics Holdings, Inc. (NASDAQ:RANI – Get Free Report) saw a significant drop in short interest in the month of May. As of May 15th, there was short interest totalling 871,200 shares, a drop of 29.7% from the April 30th total of 1,240,000 shares. Based on an average daily volume of 148,400 shares, the days-to-cover […]

Related Keywords

United States , , Nasdaq , Exchange Commission , Rani Therapeutics Holdings Inc , Canaccord Genuity Group , Vanguard Group Inc , Rani Therapeutics Holdings , Get Free Report , Rani Therapeutics , Free Report , Genuity Group , Therapeutics Holdings , Rani Therapeutics Daily ,